To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with Type 2 Diabetes

Condition	Treatment or Intervention	Phase
Obesity Diabetes Mellitus, Non-Insulin-Dependent Obesity in Diabetes	Drug: Rimonabant	Phase III

Further Study Details: 

Expected Total Enrollment:  370

Ages Eligible for Study:  18 Years   -   70 Years,  Genders Eligible for Study:  Both

Criteria

• BMI must be greater than 27 and less than 40
• Treated Type 2 Diabetes on single therapy treatment for at least 1 year
• Stable weight (variation of less than 5 kg within 3 months prior to screening visit)

Alabama
      Innovative Clinical Trials, Birmingham,  Alabama,  35209,  United States
Arizona
      Advanced Clinicla Therapeutics, LLC, Tucson,  Arizona,  85712,  United States
      Lovelace Scientific Resources, Phoenix,  Arizona,  85016,  United States
California
      Southern California Prevention and Research Center Inc. (SPARC), Encino,  California,  91436,  United States
      Diablo Clinical Research, Inc., Walnut Creek,  California,  94598,  United States
      Anderson Clinical Research, San Bernardino,  California,  92408,  United States
Connecticut
      North East Clinical Research, Hamden,  Connecticut,  06518,  United States
Florida
      Jacksonville Center for Clinical Research, Jacksonville,  Florida,  32216,  United States
      Orlando Clinical Research Center, Orlando,  Florida,  32806,  United States
      Clinical Research of South Florida, Coral Gables,  Florida,  33134,  United States
      Comprehensive NeuroScience, Inc., Sarasota,  Florida,  34232,  United States
      DMI Helathcare Group, Largo,  Florida,  33773,  United States
      Metabolic Research Institute, West Palm Beach,  Florida,  33401,  United States
      Jackson Downey, MD, Jacksonville,  Florida,  32205,  United States
      University Clinical Research, Pembroke Pines,  Florida,  33024,  United States
      Jacksonville Center for Clinical Research, Jacksonville,  Florida,  32205,  United States
Georgia
      nTouch Research, Marietta,  Georgia,  30066,  United States
      CSRA Partners in Health, Inc., Augusta,  Georgia,  30909,  United States
Indiana
      Physicians Research Group, Indianapolis,  Indiana,  46250,  United States
      MediSphere Medical Research Center, LLC, Evansville,  Indiana,  47714,  United States
Kansas
      Kansas University Medical Center, Kansas City,  Kansas,  66160,  United States
Louisiana
      Medical Research Institute, Slidell,  Louisiana,  70458,  United States
      Gulf States Clinical Trails, LLC, Kenner,  Louisiana,  70062,  United States
Maine
      Androscoggin Cardiology Associates, Auburn,  Maine,  United States
Massachusetts
      Phase III Clinical Research, Fall River,  Massachusetts,  02720,  United States
      JM Clinical Trials, Inc., Swansea,  Massachusetts,  02777,  United States
Minnesota
      Twin Cities Clinical Research, Arden Hills,  Minnesota,  55126,  United States
Nevada
      Lovelace Scientific Resources, Las Vegas,  Nevada,  89014,  United States
New Hampshire
      Endocrinology and Diabetes Consultants, PC, Dover,  New Hampshire,  03820,  United States
New Jersey
      Radiant Reseach-Moorestown, Moorestown,  New Jersey,  08057,  United States
New Mexico
      Lovelace Scientific Resources, Albuquerque,  New Mexico,  87108,  United States
New York
      Physician Clinical Research Service, White Plains,  New York,  10605,  United States
North Carolina
      Center for Nutrition and Preventive Medicine, Charlotte,  North Carolina,  28207,  United States
Ohio
      Radiant Research, Cincinnati,  Ohio,  45236,  United States
      MFP Research, Inc., Cincinnati,  Ohio,  45242,  United States
Oklahoma
      University of Oklahoma Health Sciences Center, Oklahoma City,  Oklahoma,  73104,  United States
Oregon
      Radiant Research, Portland,  Oregon,  97201,  United States
South Carolina
      Medical University of South Carolina, Division of Clinical Pharmacology, Charleston,  South Carolina,  29425,  United States
      Costal Carolina Research Center, Mt. Pleasant,  South Carolina,  29464,  United States
Tennessee
      TriCities Medical Reseach, Bristol,  Tennessee,  37620,  United States
Texas
      Diabetes $ Glandular Disease Clinic, PA, San Antonio,  Texas,  78229-4810,  United States
Utah
      Endocrine and Diabetes, Ogden,  Utah,  84403,  United States
Virginia
      National Clinical Research, Richmond,  Virginia,  23294,  United States
      Salem Veterans Affairs Medical Center (151), Salem,  Virginia,  24153,  United States
      The Chase Wellness Center, Inc., Virginia Beach,  Virginia,  23455,  United States

Study ID Numbers:  EFC4736; SR141716
Record last reviewed:  May 2003
Last Updated:  October 13, 2004
Record first received:  January 23, 2002
ClinicalTrials.gov Identifier:  NCT00029848
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08